Randomized trial · people

NAD+: NR and NMN, not nicotinamide, raised blood NAD+ in 14 days

Checked against the paper Randomized trialPublished by PepVault

The takeaway

In a short head-to-head trial, NR and NMN raised blood NAD+ comparably over 14 days while nicotinamide did not, and the team proposes that gut microbes help explain how NR and NMN work.

Kind
Randomized trial
Studied in
People
Number studied
65
Published
2026
Journal
Nat Metab

What they tested

The team set out to compare, head to head in people, how three common NAD+ boosters change NAD+ levels in the blood, and what gut microbes do with them.

How the study was done

A randomized, open-label (everyone knew what they were taking), placebo-controlled trial in 65 healthy participants who took nicotinamide (Nam), nicotinamide riboside (NR), nicotinamide mononucleotide (NMN) or placebo for 14 days. The team also ran lab tests outside the body, using human gut microbes and whole blood samples.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

After 14 days, NR and NMN raised circulatory NAD+ by a similar amount, while Nam did not. Nam was the only one that briefly changed the mix of NAD+-related compounds in whole blood soon after a dose. In lab tests with human gut microbes, NR and NMN were turned into nicotinic acid (NA) and boosted microbial growth and activity. In whole blood samples tested in the lab, NA strongly raised NAD+, while NMN, NR and Nam did not.

What it doesn’t show

The trial was short, open-label and in healthy adults only, so it doesn't show effects in people with health conditions or over longer use. The gut microbe and blood tests were done outside the body, and the gut-based explanation is a model the team proposes rather than one tested directly in people.

The paper

Christen et al. The differential impact of three different NAD+ boosters on circulatory NAD and microbial metabolism in humans. Nat Metab. 2026.

The compound

More studies on NAD+

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking NAD+? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo